Upadacitinib (Rinvoq) is a JAK inhibitor drug used to treat joint damage in rheumatoid arthritis and psoriatic arthritis.
Ustekinumab is used to treat psoriasis and psoriatic arthritis. Find out how long it takes to work, how it’s taken and possible side-effects.